NCT03884842 Dupilumab on Airway Hyper-responsiveness and Ventilation Heterogeneity in Patients With Asthma. Status COMPLETED Phase PHASE3
NCT03874715 Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Status COMPLETED Phase PHASE3
NCT03871348 A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03860844 Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Status TERMINATED Phase PHASE2
NCT03856619 To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT03849716 Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03829501 A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT03816839 Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2) Status TERMINATED Phase PHASE1
NCT03802487 Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT03798080 Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin Status COMPLETED Phase PHASE3
NCT03798054 Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s) Status COMPLETED Phase PHASE3
NCT03794336 Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive Status COMPLETED Phase PHASE4
NCT03793608 Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy Status COMPLETED Phase PHASE2
NCT03782532 Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma Status COMPLETED Phase PHASE3
NCT03776227 A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions Status COMPLETED Phase PHASE1
NCT03770728 Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea Status TERMINATED Phase PHASE3
NCT03769181 A Study of Isatuximab-based Therapy in Participants With Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT03767543 Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE3
NCT03761134 Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea Status TERMINATED Phase PHASE3